You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis
|
---|---|
Published in |
Cochrane database of systematic reviews, November 2014
|
DOI | 10.1002/14651858.cd004197.pub4 |
Pubmed ID | |
Authors |
Simon C Langton Hewer, Alan R Smyth, Langton Hewer SC, Smyth AR, Langton Hewer, Simon C, Smyth, Alan R |
Abstract |
Respiratory tract infection with Pseudomonas aeruginosa occurs in most people with cystic fibrosis. Once chronic infection is established, Pseudomonas aeruginosa is virtually impossible to eradicate and is associated with increased mortality and morbidity. Early infection may be easier to eradicate.This is an update of a Cochrane review first published in 2003, and previously updated in 2006 and 2009. |
X Demographics
The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 3 | 30% |
United States | 2 | 20% |
Unknown | 5 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 8 | 80% |
Scientists | 1 | 10% |
Practitioners (doctors, other healthcare professionals) | 1 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 147 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Ecuador | 1 | <1% |
Belgium | 1 | <1% |
Australia | 1 | <1% |
Unknown | 144 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 20 | 14% |
Student > Ph. D. Student | 18 | 12% |
Researcher | 17 | 12% |
Student > Master | 15 | 10% |
Student > Doctoral Student | 12 | 8% |
Other | 25 | 17% |
Unknown | 40 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 47 | 32% |
Agricultural and Biological Sciences | 14 | 10% |
Biochemistry, Genetics and Molecular Biology | 10 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 10 | 7% |
Social Sciences | 4 | 3% |
Other | 20 | 14% |
Unknown | 42 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 May 2017.
All research outputs
#2,142,023
of 24,129,125 outputs
Outputs from Cochrane database of systematic reviews
#4,649
of 12,841 outputs
Outputs of similar age
#25,171
of 264,954 outputs
Outputs of similar age from Cochrane database of systematic reviews
#107
of 257 outputs
Altmetric has tracked 24,129,125 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,841 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.9. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 264,954 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 257 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.